	"Noâ€¦ Nobody told me anything about that": a qualitative study on pretreatment knowledge of individuals with lung or head and neck cancer regarding the disease, treatments, and physical exercise. Support Care Cancer Duarte I, da Silva Souza KA, Moliterno AH, Borges P, Pedroso M, Grigoletto I, Ramos EMC. PMID: 42934371 [PubMed - indexed for MEDLINE]
	Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial. Nat Med Reck M, Nadal E, Gay CM, Girard N, Filippi AR, Martin LW, Petersen C, Cairns DA, Majem M, Ardizzoni A, Alvarez RA, Robinson A, Roch B, Boyer A, Attili I, Diehn M, Kurtz D, Emeribe UA, Perez ID, Levra MG, Gale D, Zhu Z, Georgoulia N, Spicer J. PMID: 42934326 [PubMed - as supplied by publisher]
	[Cancer or chronic infection: Diagnostic challenges of pulmonary botryomycosis]. Rev Mal Respir Fragneau R, Paillat C, Berti V, Debray MP, Mordant P, Taillé C, Guyard A, Garinat M. PMID: 42934011 [PubMed - as supplied by publisher]
	Experience of participating in a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in stage III-N2 non-small cell lung cancer: PIONEER. BMJ Open Respir Res Perry MB, Ward A, Baldwin DR, Blackhall F, Eastwood C, Edwards J, Evison M, Faivre-Finn C, Grundy S, Harris E, Navani N, Rhodes S, Robson J, Tsim S, Van Schil P, Woolhouse I, Yorke J, Taylor S. PMID: 42933815 [PubMed - in process]
	Final Analysis of the Neotorch Study: Perioperative Toripalimab in Combination with Chemotherapy for Patients with Stage â…¡/â…¢ Resectable Non-Small Cell Lung Cancer. Ann Oncol Li ZM, Wu L, Wang WX, Sun LH, Zhang P, Fang WT, Zheng Y, Chen QX, Yang L, Tan LJ, Mei JD, Shan JL, Xu SD, Sun XH, Yang N, Hu XH, Yu GH, Yu DL, Chen YP, Xing LG, Liu YP, Tian H, Chen KN, Wu N, Cao LJ, Zhou M, Fang HH, Zhang X, Jiang J, Li XY, Kang MQ, Ye MH, Sun Q, Li SQ, Wu GW, Xu HP, Zhu KS, Zhong AH, Zhu LM, Wang CL, Zhang Y, Cai KC, Ma HT, Chen J, Hu H, Yang ZX, Zhang WG, Hang XS, Zhang XC, Hu J, Huang YC, Yao J, Zhang ZY, Zhang LW, Liu LX, Wang WH, Wei SH, Cao DZ, Zou JJ, Lu S. PMID: 42933639 [PubMed - as supplied by publisher]
	Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase 3 DeLLphi-304 study. Ann Oncol Rudin CM, Ahn MJ, Schuler M, Blackhall FH, Mountzios G, Yoshida T, Sun L, Cho BC, Lugini A, Arulananda S, Punekar SR, Rocha P, Paz-Ares L, Mazières J, Gümü, Demirci U, Huang S, Abidi B, Patil U, Zhu B. PMID: 42933636 [PubMed - as supplied by publisher]
	Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China. Lancet Hong S, Zhou T, Hou X, Meng X, Hu Z, Zheng W, Cui J, Luo Y, Wu L, Huang M, Xu H, Hu J, Zhao Y, Yao W, Hong Y, Cai J, Zhang Y, Su C, Xie C, Wang R, Li X, He Q, Zhang L, Ning R, Lin D, Zhang T, Yi T, Zhong L, Huang S, Zhao H, Fang J, Bu Q, Li B, Zhang Z, Shi M, Shi J, Deng Z, Zhu Y, Zhu H, Xiao S, Yang L, Song N, Fang W, Zhang L, Yang Y, PANKU-Lung01 Investigators. PMID: 42933461 [PubMed - as supplied by publisher]
	Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China. Lancet Xu CR, Zhang Y, Lin G, Wang H, Wang Q, Huang D, Yu Y, Zhou J, Zhong H, Wu L, Liu L, Duan J, He Z, Luo Y, Liu H, Chen B, Yu X, Xue F, Chu Q, Guo S, Yang R, Zhong J, Liu H, Sun L, Dong X, Su H, Zhang P, Yang B, He S, Ji Y, Wan L, Han X, Zhang J, Qiu F, Yang L, Shi W, Wu YL, HERON-Lung01 Investigators. PMID: 42933457 [PubMed - as supplied by publisher]
	Effects of Temporal Information Structure on Causal Explanations Generated by Large Language Models: Experimental Study Using Lung Cancer Incidence Data. J Med Internet Res Jeong E, Jeong W, Oh KH, Jun JK. PMID: 42932869 [PubMed - indexed for MEDLINE]
	Transporting Lung Cancer Screening Effects From National Lung Screening Trial to a US Screening-Eligible Population. JCO Clin Cancer Inform Su IH, Henderson LM, Chen X, Hudgens MG, Reuland DS, Rivera MP, Schlusser C, Stürmer T, Webster-Clark M, Lund JL. PMID: 42932790 [PubMed - indexed for MEDLINE]
	Early Clinical Evaluation of AI Triage of Chest Radiographs: Time to Diagnosis for Suspected Cancer and Number of Urgent CT Referrals. NEJM AI Storey M, Packer J, Grandal NS, Rhodes A, Moon J, Togher D, Abubacker Z, Rickaby S, Dean G, Shelmerdine SC. PMID: 42932526 [PubMed - indexed for MEDLINE]
	Effect of Intratumoral PD-L1 Expression on Treatment Efficacy of ALK Tyrosine Kinase Inhibitors for Advanced or Recurrent ALK-Positive Non-small Cell Lung Cancer. Med Oncol Sawada R, Yamada T, Goto Y, Negi Y, Nakao A, Yoshimura A, Furuya N, Oba T, Hibino M, Nakatani H, Taniguchi H, Ohtsubo A, Watanabe S, Yamada T, Chihara Y, Kijima T, Takayama K. PMID: 42932091 [PubMed - indexed for MEDLINE]
	ENTRÃ‰E Lung: An Open-label Platform Study Investigating the Safety and Pharmacokinetics of Belrestotug Combinations in Advanced Non-Small Cell Lung Cancer. Clin Cancer Res Spigel DR, Lo Russo G, Cousin S, Garrido P, Chu Q, Medina Rodriguez L, Sacher A, Cheema P, D'Arcangelo M, Rossi G, Majumdar A, Hanafin P, Georgouli M, Mozaffari R, Kijewska M, Theti D, Baxter D, Trinchese F, Diaz-Padilla I, Reck M. PMID: 42931848 [PubMed - as supplied by publisher]
	Relative CT Number as a Quantitative Imaging Biomarker for Differentiating Sinonasal Polyp, Inverted Papilloma, and Squamous Cell Carcinoma: A Preliminary Retrospective Study. Tomography Öztürk Ta, Akyüz S, Tuzcu G. PMID: 42931495 [PubMed - indexed for MEDLINE]
	Preoperative Advanced Lung Cancer Inflammation Index and Acute Kidney Injury After Adult Cardiac Surgery: A Retrospective Cohort Study. J Cardiovasc Dev Dis Gan H, Zhang R, Fan R, Yin L, Ning S, Wang J, Liu D, Chen W, Chen X, Qiu Z. PMID: 42930886 [PubMed]
	AI-Generated Treatment Recommendations in Newly Diagnosed Lung Cancer: A Single-Center Feasibility Study in a Resource-Limited Setting. Curr Oncol Popescu A, Jidveian-Popescu M, Mahler B, Olteanu R, Clem E. PMID: 42930207 [PubMed - indexed for MEDLINE]
	Skeletal Muscle Index and Baseline Biomarkers in Atezolizumab-Treated Extensive-Stage Small-Cell Lung Cancer: A Real-World Cohort Study. Curr Oncol Güçlü Kantar T, Do, Yapar Ta, Demiray AG, Yaren A, , Gököz Do. PMID: 42930206 [PubMed - indexed for MEDLINE]
	Olink Platform-Based Identification of Peripheral Blood Biomarkers for irAEs in Advanced NSCLC. Curr Oncol Zhang Z, Chen B, Jiang H, Zhang Z, Mo J, Hou Y, Liu S, Xu P. PMID: 42930174 [PubMed - indexed for MEDLINE]
	Cancer Immunotherapy and Immune-Related Adverse Events: Focusing on Non-Small Cell Lung Cancer. Curr Oncol Kamil A, Cowles S, Driver CC, Arora A, Swyers MM, Boldt LW, Muzaffar M, Batoo SA, Yang LV. PMID: 42930173 [PubMed - indexed for MEDLINE]
	Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study. Curr Oncol Ren Z, Lu J. PMID: 42930170 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 163016

Page 1 of 8151



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy